| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |